Jeremy M. Levin
Member, Scientific Committee
Molecular biology,
Lundbeck Pharmaceuticals
Belgium
Biography
Jeremy M. Levin is a British and US citizen and was elected to Lundbeck's board of Directors in 2017. Jeremy M. Levin has more than 25 years of experience in the global pharmaceuticals industry, leading companies and people to develop and commercialize medicines that address compelling medical needs worldwide. He also serves as CEO and chairman of Ovid Therapeutics, a New York-based neurology company focused on rare and orphan diseases of the brain.
Research Interest
Pharmaceutical Sciences
